❖
❖
❖
Cancer
❖
Intravenous Vitamin C:
❖
An Extraordinary Natural Chemotherapy
and Immunotherapy Agent
❖
Cancer
❖
Intravenous Vitamin C:
❖
An Extraordinary Natural Chemotherapy
and Immunotherapy Agent
❖
❖
Home
Cancer
Intravenous Vitamin C:
An Extraordinary Natural Chemotherapy and Immunotherapy Agent
This peer-reviewed paper by Envita was written to help both patients and health professionals learn more about the benefits of Vitamin C. The history of Vitamin C began with James Lind's observations in 1747 that British sailors at sea for long periods of time did not develop scurvy if they ate oranges or lemons with regularity.
The Vitamin C molecule was isolated in the late 1920's and was being produced synthetically within a decade. Linus Pauling and his colleagues were among the first scientists to laud the potential value of Vitamin C as a supportive therapy for cancer.
Vitamin C - Natural Cancer Treatment Serves Direct Cytotoxicity Killing on Cancer
In vitro studies have demonstrated that Vitamin C has anti-tumor cytotoxic activity at doses higher than 1000 μmol/L.
Casciari et. al. showed that the concentrations of Vitamin C necessary to kill hollow fiber tumors in vitro, could be achievable in vivo. Vitamin C produces hydrogen peroxide on oxidation – long considered to be a primary mechanism of its anti-tumor activity. Levine and colleagues published evidence that Vitamin C delivers hydrogen peroxide to cancer cells in vitro, accounting for this tumor cytotoxic activity.
Vitamin C Works as an Anti-Angiogenic Agent
Although considerable interest has been given to the ability of Vitamin C to enhance chemotherapy drugs' action, a more recent finding is that the Vitamin can modulate the expression of the transcription factor hypoxia-inducible factor 1 (HIF-1).
HIF-1 is key to basic cell metabolism and controls cellular response to hypoxia. HIF-1 regulates several genes' enzyme and protein coding involved in glycolysis and angiogenesis.6 Angiogenesis in particular is key to tumor growth and HIF-1 has been shown to be present in the hypoxic core of some tumors.
What is Genetically Targeted Fractionated Chemotherapy?
Currie and colleagues have recently reported the results of a study investigating the effects of Vitamin C on HIF-1 expression in human umbilical vein endothelial cells and human skin fibroblast cell lines. In this report, both untreated cells and cells treated with either CoCl2 or hypoxia (to induce HIF-1 expression) were analyzed for their differential response to Vitamin C.
The addition of Vitamin C significantly decreased expression of HIF-1 in treated cells, in which HIF-1 expression had been induced. In untreated cells, low basal levels of HIF-1 were present, but the addition of Vitamin C to these cells completely abolished HIF-1.
To assess the impact of Vitamin C on the expression of genes controlled by HIF-1, VEGF mRNA levels were examined. Vitamin C significantly diminished CoCl2-induced VEGF mRNA expression, but had no effect on VEGF mRNA in cells treated with hypoxia.
Since VEGF is one of the key growth factors contributing to the process of angiogenesis, these findings are of particular interest. These findings mirror those of Ratcliffe and colleagues. This team investigated the addition of Vitamin C to several cancerous cell lines, including PC-3 (prostate), OVCAR3 (ovarian), and HS578T, MDA 468, and MCF-7 (all breast cancer cell lines). Vitamin C diminished HIF-1 expression, VEGF mRNA expression and VEGF secretion in these cells.
More Encouraging Data for Vitamin C Utilized as an Chemotherapeutic Agent
Salnikow and colleagues, in a joint effort between the National Cancer Institute and Brown University, investigated the effects of ascorbate depletion on the expression of the hypoxia-associated proteins NDRG1/Cap43 and CA IX in the 1HAEo- human lung epithelial cell line.
Following treatment of these cells with nickel, ascorbate was rapidly depleted from these cells, and the expression of HIF-1 as well as NDRG1/Cap43 and CA IX was increased. Subsequent re-addition of ascorbate to these cells reversed these effects.
Likewise, pretreatment of 1HAEo- cells with ascorbate, followed by addition of nickel, completely inhibited the induction of these proteins.
Currently, angiogenesis inhibitors such as Avastin, Nexavar, and Sutent are FDA-approved drugs for use in the treatment of cancer. The recent discovery of the anti-angiogenic effects of Vitamin C are promising and further support the use of high-dose intravenous Vitamin C as an adjuvant treatment for cancer.
Vitamin C and Natural Treatment -
NIH and it's Hisory with PaulingIn 1976, Pauling and Cameron published one of the first studies of supplemental Vitamin C administration in patients with terminal cancer. 100 terminal cancer patients received intravenous Vitamin C doses of 10 g per day for 10 days and then orally thereafter. 1,000 cancer patients served as the control group and did not receive Vitamin C in any form.
Mean survival time for patients receiving Vitamin C was more than 4.2 times that of the control group. A retrospective analysis of this study, published in 1978, found that 22% of patients receiving Vitamin C had greater than 1 year survival even after being pronounced terminal, compared with 0.4% of the control group.
Levine and colleagues at the National Institute of Health recently published results of a modest trial investigating the pharmacokinetics of Vitamin C in plasma. Various doses of both oral and intravenous Vitamin C were administered to 17 healthy volunteers. In this cohort, mean peak plasma values of Vitamin C were shown to be significantly elevated following intravenous Vitamin C, compared to oral administration of Vitamin C.
At the highest intravenous dose of 1.25 grams, peak plasma values were nearly 7 times higher than plasma values for an oral dose of 1.25 grams. Importantly, plasma levels of Vitamin C continued to increase with increasing intravenous doses, whereas increasing oral doses eventually reached a plateau effect.
These researchers concluded that intravenous administration of Vitamin C could achieve 70-fold higher ascorbate levels in blood than the maximum tolerated oral dose. In 2006, Levine published three case studies of advanced cancer patients who had received high-dose intravenous Vitamin C therapy.11 In all cases, patients achieved remission for at least 4 years.
More Clinical Data Supporting Vitamin C as a Natural Cancer Treatment
Song and colleagues recently published the results of a clinical trial involving administration of intravenous Vitamin C in 39 terminal cancer patients.
Patients answered quality of life questionnaires before and after treatment. A significant increase in quality of life scores was noted following Vitamin C administration. Moreover, patients reported significantly higher scores for physical, role, cognitive and emotional function, with significantly lower scores for pain, fatigue, nausea/vomiting, loss of appetite, and sleep disturbance after receiving Vitamin C.
Multiple studies have demonstrated the ability of Vitamin C to increase the efficacy of chemotherapy. Lamson and Brignall's 1999 review of antioxidant use with cancer patients emphasized that Vitamin C increases the chemotherapeutic effects of doxorubicin, cisplatin, vincristine, and paclitaxel in in vitro studies. Likewise, Vitamin C given prior to chemotherapy in animal studies increased survival time and the effect of several chemotherapeutics, including cyclophosphamide and 5-FU.
Hunter and colleagues published case studies of two advanced ovarian cancer patients who both received carboplatin, paclitaxel, and intravenous Vitamin C at a dose of 60 g/day twice a week for several months. One woman in this study was found to have complete remission of her disease, and the other woman maintains low CA-125 levels more than 3 years following her diagnosis. Administration of intravenous Vitamin C in these patients did not diminish the effectiveness of the chemotherapy regimen, nor did it exacerbate its toxicity.
The Effects of Vitamin C on a Patient's Immune function
The effects of Vitamin C on immune function are extremely varied. The immune system relies heavily on endogenously produced ROS (such as H2O2) and reactive nitrogen species (such as NO) as a means of immune activation during times of infection and inflammation. The high cellular concentration of Vitamin C and its rapid decline in plasma and leukocytes during stress and infection also suggest a direct role in the immune response.
This observed decrease of plasma and leukocyte Vitamin C levels during infective periods suggests that the increased generation of ROS is counteracted by reaction with Vitamin C, protecting host immune cells. While cells of the immune system release ROS and NO during periods of immune activation, Vitamin C helps protect the immune system from its own weapons by quenching these radicals.
For instance, Vitamin C has been demonstrated to protect neutrophils from ROS generated during phagocytosis. Vitamin C supplementation also significantly decreased H2O2-induced DNA damage in lymphocytes in healthy male and female nonsmokers.
In studies in healthy subjects, administration of Vitamin C resulted in improvement of several components of human immune parameters, such as antimicrobial and NK cell activities, lymphocyte proliferation, chemotaxis, and delayed-type hypersensitivity (DTH). Even in elderly adults known to have reduced Vitamin C plasma and leukocyte concentrations, Vitamin C supplementation resulted in enhanced cell-mediated immunity and improved serum immunoglobulin levels.
Vitamin C - Helping 80% of Late Stage Cancer Patients Face Life-Threatening Infections
The use of Vitamin C as adjuvant or prophylactic treatment for infectious disease is not without precedent.
Linus Pauling, the Nobel Prize winning chemist, lauded the benefits of Vitamin C for prevention of the common cold for decades. Hemila recently published a review of 12 clinical trials, performed separately, that assessed the efficacy of Vitamin C supplementation in respiratory infections in military personnel and students living in crowded quarters.
After reviewing these studies, the author concluded that Vitamin C substantially reduced the incidence and severity of respiratory infections in several of these trials.16 Kodama and colleagues reported that over a 10-year period, high-dose intravenous Vitamin C proved to be effective for the clinical control of patients with interstitial pneumonia, an autoimmune disease associated with chronic fatigue syndrome.
Chuang and colleagues recently reported the results of Vitamin C supplementation on triple antibiotic therapy (omeprazole, amoxicillin, and clarithromycin) for eradication of H. pylori in 171 subjects.
Patients receiving Vitamin C had significantly higher eradication rates than those who did not, and allowed for lower dosages of clarithromycin without losing efficacy.
Clinical Studies of Vitamin C in Relation to Cardiovascular Disease and Smoking
Willett and colleagues at Harvard Medical School reported in 2003 on the results of a 16-year longitudinal study of 85,118 women that assessed the impact of Vitamin C supplementation on the risk of coronary heart disease (CHD).
Approximately 19% of participants supplemented their Vitamin C intake. After adjusting for a number of coronary risk factors such as age, smoking incidence, and use of other dietary antioxidants, women who used Vitamin C supplements had a 28% lower incidence of CHD than women who did not.
Suh et. al. investigated the relationship between Vitamin C intake and ischemic heart disease in 108 Korean men. (Because Korean men have among the highest prevalence of smoking in the world, this study also factored smoking into the variables considered.) Of the 108 participants of this study, 58 had new onset angina pectoris and 50 had a first acute myocardial infarction.
Vitamin C supplements were not employed in this study; rather, the participants were allowed to eat their normal diet, which was assessed by a nutritionist to determine daily Vitamin C intake.
Participants were first stratified into three major groups based on daily Vitamin C intake and then further placed into subgroups based on whether they were current smokers, ex-smokers, or non-smokers. After evaluation, daily intake of Vitamin C was directly related to a lower incidence of non-fatal ischemic heart disease.
Specifically, those participants who currently smoked and had low daily intake of Vitamin C (< 141.8 mg) were over 8 times more likely to have non-fatal ischemic heart disease than non-smokers who had either medium (141.8-220.2 mg) or high (> 220.2 mg) daily intake of Vitamin C.
Current smokers with high daily Vitamin C intake had only 1/3 the risk level than current smokers with low daily Vitamin C intakes. The researchers concluded that high daily Vitamin C intake decreased the risk of ischemic heart disease, even in patients who continued to smoke.
Oxidative Stress
Misra's research team investigated the effect of Vitamin C supplementation on oxidative stress parameters in 80 patients who had suffered a myocardial infarction and were in the post-reperfusion phase. Ischemia plays a dominant role in the pathogenesis of both myocardial infarction and stroke. Under ischemic conditions, an increase in the levels of oxidative stress markers occurs.
Specifically, ischemia results in increases in xanthine and xanthine oxidase, which produce free radicals in the presence of oxygen. Because levels of these free radicals increase as ischemia continues, the establishment of reperfusion to myocardial tissue can actually result in transient, or even permanent myocardial injury.22
This study reported that following thrombotic events that caused ischemia, thrombolytic therapy resulted in significant decreases (compared to pre-thrombolytic therapy levels) in superoxide dismutase (SOD) and total thiols – two important oxygen radical scavenging enzyme systems.
Supplementation of 1000 mg Vitamin C for five days in these patients resulted in significant increases in these enzymes, compared to both pre- and post-thrombolytic therapy levels, as SOD and total thiol levels were at their highest following Vitamin C supplementation.
Likewise, levels of the oxygen radicals xanthine oxidase (XO) and malondialdehyde (MDA) were significantly elevated in ischemic patients in the post-reperfusion period compared to pre-thrombolytic therapy levels.
These oxygen radicals were significantly decreased following Vitamin C supplementation, compared to both pre- and post-thrombolytic therapy levels – XO and MDA levels were at their lowest in these patients following Vitamin C supplementation.
Heart and Muscle Contractility -
The Effects of Chemotherapy and Radiation on the Heart
In 2007, Yokoyama's team published the results of a Japanese study that investigated the effects of Vitamin C and dobutamine on myocardial contractility in patients with heart failure following anterior myocardial infarction. Dobutamine is a selective agonist that promotes increased cardiac output in patients with heart failure. Ten patients were selected for the Vitamin C group, with 9 controls.
Cardiac catheterization was performed to achieve direct measurement of several hemodynamic and contractile factors. This study found that Vitamin C significantly enhanced the response of left ventricular contractility and left ventricular stroke work, above the increases in these factors that occurred in response to ß-1 adrenergic stimulation.
Further, this enhancement of myocardial efficiency by Vitamin C did not result in increased myocardial oxygen consumption. These data suggest that Vitamin C is a safe and effective adjuvant therapy for patients with heart failure.
Take a Tour of Envita Medical Centers
In 2003, Martin and colleagues at Tufts Medical School published the findings of their investigation of plasma Vitamin C levels in patients following ischemic stroke. Fifteen ischemic stroke patients and 24 control subjects participated in this study. Plasma levels of Vitamin C and other oxidative stress and inflammatory markers were measured 2 to 5 days following ischemic events in the 15 subjects.
Despite having similar Vitamin C dietary intakes, ischemic stroke patients had significantly reduced plasma Vitamin C levels compared to controls, as measured by paired-ion, reverse-phase HPLC coupled with electrochemical detection. Interestingly, plasma Vitamin C levels had a strong inverse correlation with CRP levels in this cohort, suggesting that Vitamin C may play a critical role in the stroke-mediated inflammatory response.
Vitamin C for Stroke and Cancer Patients with Clotting Problems
In January 2008, Khaw and colleagues published peripheral findings from the ten-year European Prospective Investigation into Cancer (EPIC) study concerning Vitamin C and incidence of stroke. 20,649 men and women, ages 40 to 79 and without history of stroke at baseline, participated in this longitudinal study.
Participants submitted health questionnaires at various intervals over the ten-year time frame, per study protocol. Based on their responses to the study questionnaires, participants were stratified into four groups based on their reported daily Vitamin C intake. After evaluating participant questionnaires, the researchers found that those people in the quartile that reported the highest daily Vitamin C intake had a 42% lower relative risk of stroke than those people in the bottom quartile (lowest daily Vitamin C intake among study participants).
This decrease in relative stroke risk was found to be independent of age, sex, smoking habits, BMI, systolic blood pressure, cholesterol, physical activity, prevalent diabetes, myocardial infarction, social class, alcohol consumption, and any supplement use. Overall, the researchers reported that there was a 17% reduction in incident stroke for every 20 micromoles per liter increase in plasma Vitamin C concentration.
This peer-reviewed paper has demonstrated that Vitamin C is a warranted adjuvant therapy for patients with cancer. The in vitro cytotoxicity of Vitamin C has been noted in several different types of cancer cell lines, and ability of Vitamin C to enhance the effectiveness of chemotherapy has also been reported.
Clinical studies of Vitamin C supplementation in cancer patients have suggested that adjuvant use, especially by intravenous delivery, has therapeutic efficacy. The potent antioxidant activity of Vitamin C also results in direct enhancement in immune functioning. Supplementation of Vitamin C resulted in synergistic enhancement of triple antibiotic therapy in patients with H. pylori infection.
Recent publications have demonstrated that daily intake of Vitamin C is directly correlated with decreased risk of coronary heart disease, myocardial infarction, and stroke. Patients with myocardial infarction and/or ischemic stroke both present with decreased levels of Vitamin C shortly after symptom exacerbation. This decrease in Vitamin C levels has been shown to be statistically significant compared to control subjects.
Vitamin C supplementation in myocardial infarction patients resulted in increased levels of protective antioxidant enzymes and decreased levels of inflammatory and oxidative stress markers. Vitamin C worked synergistically with dobutamine in patients with heart failure secondary to anterior myocardial infarction, resulting in increased left ventricular contractility and stroke work. Importantly, the observed increase in left ventricular efficiency did not result in increased myocardial oxygen consumption.
Envita Medical Centers and Intravenous Vitamin C
Contact us to learn more about our speed drip intravenous Vitamin C technology, including our sustained released intravenous Vitamin C technology that we have found to be clinically superior to all others. In addition, we do not ever use corn-derived GMO Vitamin C with patients; rather, we utilize far cleaner sources that we believe makes a difference. Inquire today to learn more.
References
Latest Cancer Articles
Metabolic and Gerson Therapies in Integrative Cancer Care
Metabolic and Gerson therapies focus on diet and detoxification to influence cancer metabolism. Envita integrates these principles within precision oncology, personalizing care with genomic testing and immune optimization to target cancer’s root drivers and improve patient outcomes.
Why Passive Cancer Monitoring May Increase Risk
Advanced diagnostics and targeted immunotherapies can reduce anxiety and improve follow-up care after cancer treatment
The watch-and-wait cancer approach may delay recurrence detection and limit treatment options. Envita Medical Centers uses precision oncology, liquid biopsies, and personalized immunotherapies to detect micro metastases early and reduce recurrence risks through active, targeted care.
Advocating for Medical Freedom in U.S. HealthcareEmpowering Patients and Physicians in the
Face of Chronic and Terminal Illness
Medical freedom empowers patients and doctors to choose personalized, evidence-based treatments beyond insurance restrictions. Envita Medical Centers champions healthcare freedom, offering integrative and precision options designed to improve outcomes and quality of life.
Value-Based Precision Oncology with Transparent Pricing
Envita’s value-based precision oncology combines advanced genomic testing, personalized immunotherapy, and transparent pricing to deliver patient-centered cancer care focused on results—not profits. This approach improves outcomes and lowers costs for cancer patients nationwide.
Employers Partner with COEs for Precision Cancer Care
Employers are partnering with Envita’s Center of Excellence to lower oncology costs and deliver precision cancer care. Using genomic testing and value-based treatments, Envita provides personalized therapies that improve outcomes and help employees recover with fewer side
- Cancer
- Intravenous Vitamin C:
- An Extraordinary Natural Chemotherapy and Immunotherapy Agent
Cancer
Intravenous Vitamin C:
An Extraordinary Natural Chemotherapy and Immunotherapy Agent
This peer-reviewed paper by Envita was written to help both patients and health professionals learn more about the benefits of Vitamin C. The history of Vitamin C began with James Lind's observations in 1747 that British sailors at sea for long periods of time did not develop scurvy if they ate oranges or lemons with regularity.
The Vitamin C molecule was isolated in the late 1920's and was being produced synthetically within a decade. Linus Pauling and his colleagues were among the first scientists to laud the potential value of Vitamin C as a supportive therapy for cancer.
Vitamin C - Natural Cancer Treatment Serves Direct Cytotoxicity Killing on Cancer
In vitro studies have demonstrated that Vitamin C has anti-tumor cytotoxic activity at doses higher than 1000 μmol/L.
Casciari et. al. showed that the concentrations of Vitamin C necessary to kill hollow fiber tumors in vitro, could be achievable in vivo. Vitamin C produces hydrogen peroxide on oxidation – long considered to be a primary mechanism of its anti-tumor activity. Levine and colleagues published evidence that Vitamin C delivers hydrogen peroxide to cancer cells in vitro, accounting for this tumor cytotoxic activity.
Vitamin C Works as an Anti-Angiogenic Agent
Although considerable interest has been given to the ability of Vitamin C to enhance chemotherapy drugs' action, a more recent finding is that the Vitamin can modulate the expression of the transcription factor hypoxia-inducible factor 1 (HIF-1).
HIF-1 is key to basic cell metabolism and controls cellular response to hypoxia. HIF-1 regulates several genes' enzyme and protein coding involved in glycolysis and angiogenesis.6 Angiogenesis in particular is key to tumor growth and HIF-1 has been shown to be present in the hypoxic core of some tumors.
What is Genetically Targeted Fractionated Chemotherapy?
Currie and colleagues have recently reported the results of a study investigating the effects of Vitamin C on HIF-1 expression in human umbilical vein endothelial cells and human skin fibroblast cell lines. In this report, both untreated cells and cells treated with either CoCl2 or hypoxia (to induce HIF-1 expression) were analyzed for their differential response to Vitamin C.
The addition of Vitamin C significantly decreased expression of HIF-1 in treated cells, in which HIF-1 expression had been induced. In untreated cells, low basal levels of HIF-1 were present, but the addition of Vitamin C to these cells completely abolished HIF-1.
To assess the impact of Vitamin C on the expression of genes controlled by HIF-1, VEGF mRNA levels were examined. Vitamin C significantly diminished CoCl2-induced VEGF mRNA expression, but had no effect on VEGF mRNA in cells treated with hypoxia.
Since VEGF is one of the key growth factors contributing to the process of angiogenesis, these findings are of particular interest. These findings mirror those of Ratcliffe and colleagues. This team investigated the addition of Vitamin C to several cancerous cell lines, including PC-3 (prostate), OVCAR3 (ovarian), and HS578T, MDA 468, and MCF-7 (all breast cancer cell lines). Vitamin C diminished HIF-1 expression, VEGF mRNA expression and VEGF secretion in these cells.
More Encouraging Data for Vitamin C Utilized as an Chemotherapeutic Agent
Salnikow and colleagues, in a joint effort between the National Cancer Institute and Brown University, investigated the effects of ascorbate depletion on the expression of the hypoxia-associated proteins NDRG1/Cap43 and CA IX in the 1HAEo- human lung epithelial cell line.
Following treatment of these cells with nickel, ascorbate was rapidly depleted from these cells, and the expression of HIF-1 as well as NDRG1/Cap43 and CA IX was increased. Subsequent re-addition of ascorbate to these cells reversed these effects.
Likewise, pretreatment of 1HAEo- cells with ascorbate, followed by addition of nickel, completely inhibited the induction of these proteins.
Currently, angiogenesis inhibitors such as Avastin, Nexavar, and Sutent are FDA-approved drugs for use in the treatment of cancer. The recent discovery of the anti-angiogenic effects of Vitamin C are promising and further support the use of high-dose intravenous Vitamin C as an adjuvant treatment for cancer.
Vitamin C and Natural Treatment -
NIH and it's Hisory with PaulingIn 1976, Pauling and Cameron published one of the first studies of supplemental Vitamin C administration in patients with terminal cancer. 100 terminal cancer patients received intravenous Vitamin C doses of 10 g per day for 10 days and then orally thereafter. 1,000 cancer patients served as the control group and did not receive Vitamin C in any form.
Mean survival time for patients receiving Vitamin C was more than 4.2 times that of the control group. A retrospective analysis of this study, published in 1978, found that 22% of patients receiving Vitamin C had greater than 1 year survival even after being pronounced terminal, compared with 0.4% of the control group.
Levine and colleagues at the National Institute of Health recently published results of a modest trial investigating the pharmacokinetics of Vitamin C in plasma. Various doses of both oral and intravenous Vitamin C were administered to 17 healthy volunteers. In this cohort, mean peak plasma values of Vitamin C were shown to be significantly elevated following intravenous Vitamin C, compared to oral administration of Vitamin C.
At the highest intravenous dose of 1.25 grams, peak plasma values were nearly 7 times higher than plasma values for an oral dose of 1.25 grams. Importantly, plasma levels of Vitamin C continued to increase with increasing intravenous doses, whereas increasing oral doses eventually reached a plateau effect.
These researchers concluded that intravenous administration of Vitamin C could achieve 70-fold higher ascorbate levels in blood than the maximum tolerated oral dose. In 2006, Levine published three case studies of advanced cancer patients who had received high-dose intravenous Vitamin C therapy.11 In all cases, patients achieved remission for at least 4 years.
More Clinical Data Supporting Vitamin C as a Natural Cancer Treatment
Song and colleagues recently published the results of a clinical trial involving administration of intravenous Vitamin C in 39 terminal cancer patients.
Patients answered quality of life questionnaires before and after treatment. A significant increase in quality of life scores was noted following Vitamin C administration. Moreover, patients reported significantly higher scores for physical, role, cognitive and emotional function, with significantly lower scores for pain, fatigue, nausea/vomiting, loss of appetite, and sleep disturbance after receiving Vitamin C.
Multiple studies have demonstrated the ability of Vitamin C to increase the efficacy of chemotherapy. Lamson and Brignall's 1999 review of antioxidant use with cancer patients emphasized that Vitamin C increases the chemotherapeutic effects of doxorubicin, cisplatin, vincristine, and paclitaxel in in vitro studies. Likewise, Vitamin C given prior to chemotherapy in animal studies increased survival time and the effect of several chemotherapeutics, including cyclophosphamide and 5-FU.
Hunter and colleagues published case studies of two advanced ovarian cancer patients who both received carboplatin, paclitaxel, and intravenous Vitamin C at a dose of 60 g/day twice a week for several months. One woman in this study was found to have complete remission of her disease, and the other woman maintains low CA-125 levels more than 3 years following her diagnosis. Administration of intravenous Vitamin C in these patients did not diminish the effectiveness of the chemotherapy regimen, nor did it exacerbate its toxicity.
The Effects of Vitamin C on a Patient's Immune function
The effects of Vitamin C on immune function are extremely varied. The immune system relies heavily on endogenously produced ROS (such as H2O2) and reactive nitrogen species (such as NO) as a means of immune activation during times of infection and inflammation. The high cellular concentration of Vitamin C and its rapid decline in plasma and leukocytes during stress and infection also suggest a direct role in the immune response.
This observed decrease of plasma and leukocyte Vitamin C levels during infective periods suggests that the increased generation of ROS is counteracted by reaction with Vitamin C, protecting host immune cells. While cells of the immune system release ROS and NO during periods of immune activation, Vitamin C helps protect the immune system from its own weapons by quenching these radicals.
For instance, Vitamin C has been demonstrated to protect neutrophils from ROS generated during phagocytosis. Vitamin C supplementation also significantly decreased H2O2-induced DNA damage in lymphocytes in healthy male and female nonsmokers.
In studies in healthy subjects, administration of Vitamin C resulted in improvement of several components of human immune parameters, such as antimicrobial and NK cell activities, lymphocyte proliferation, chemotaxis, and delayed-type hypersensitivity (DTH). Even in elderly adults known to have reduced Vitamin C plasma and leukocyte concentrations, Vitamin C supplementation resulted in enhanced cell-mediated immunity and improved serum immunoglobulin levels.
Vitamin C - Helping 80% of Late Stage Cancer Patients Face Life-Threatening Infections
The use of Vitamin C as adjuvant or prophylactic treatment for infectious disease is not without precedent.
Linus Pauling, the Nobel Prize winning chemist, lauded the benefits of Vitamin C for prevention of the common cold for decades. Hemila recently published a review of 12 clinical trials, performed separately, that assessed the efficacy of Vitamin C supplementation in respiratory infections in military personnel and students living in crowded quarters.
After reviewing these studies, the author concluded that Vitamin C substantially reduced the incidence and severity of respiratory infections in several of these trials.16 Kodama and colleagues reported that over a 10-year period, high-dose intravenous Vitamin C proved to be effective for the clinical control of patients with interstitial pneumonia, an autoimmune disease associated with chronic fatigue syndrome.
Chuang and colleagues recently reported the results of Vitamin C supplementation on triple antibiotic therapy (omeprazole, amoxicillin, and clarithromycin) for eradication of H. pylori in 171 subjects.
Patients receiving Vitamin C had significantly higher eradication rates than those who did not, and allowed for lower dosages of clarithromycin without losing efficacy.
Clinical Studies of Vitamin C in Relation to Cardiovascular Disease and Smoking
Willett and colleagues at Harvard Medical School reported in 2003 on the results of a 16-year longitudinal study of 85,118 women that assessed the impact of Vitamin C supplementation on the risk of coronary heart disease (CHD).
Approximately 19% of participants supplemented their Vitamin C intake. After adjusting for a number of coronary risk factors such as age, smoking incidence, and use of other dietary antioxidants, women who used Vitamin C supplements had a 28% lower incidence of CHD than women who did not.
Suh et. al. investigated the relationship between Vitamin C intake and ischemic heart disease in 108 Korean men. (Because Korean men have among the highest prevalence of smoking in the world, this study also factored smoking into the variables considered.) Of the 108 participants of this study, 58 had new onset angina pectoris and 50 had a first acute myocardial infarction.
Vitamin C supplements were not employed in this study; rather, the participants were allowed to eat their normal diet, which was assessed by a nutritionist to determine daily Vitamin C intake.
Participants were first stratified into three major groups based on daily Vitamin C intake and then further placed into subgroups based on whether they were current smokers, ex-smokers, or non-smokers. After evaluation, daily intake of Vitamin C was directly related to a lower incidence of non-fatal ischemic heart disease.
Specifically, those participants who currently smoked and had low daily intake of Vitamin C (< 141.8 mg) were over 8 times more likely to have non-fatal ischemic heart disease than non-smokers who had either medium (141.8-220.2 mg) or high (> 220.2 mg) daily intake of Vitamin C.
Current smokers with high daily Vitamin C intake had only 1/3 the risk level than current smokers with low daily Vitamin C intakes. The researchers concluded that high daily Vitamin C intake decreased the risk of ischemic heart disease, even in patients who continued to smoke.
Oxidative Stress
Misra's research team investigated the effect of Vitamin C supplementation on oxidative stress parameters in 80 patients who had suffered a myocardial infarction and were in the post-reperfusion phase. Ischemia plays a dominant role in the pathogenesis of both myocardial infarction and stroke. Under ischemic conditions, an increase in the levels of oxidative stress markers occurs.
Specifically, ischemia results in increases in xanthine and xanthine oxidase, which produce free radicals in the presence of oxygen. Because levels of these free radicals increase as ischemia continues, the establishment of reperfusion to myocardial tissue can actually result in transient, or even permanent myocardial injury.22
This study reported that following thrombotic events that caused ischemia, thrombolytic therapy resulted in significant decreases (compared to pre-thrombolytic therapy levels) in superoxide dismutase (SOD) and total thiols – two important oxygen radical scavenging enzyme systems.
Supplementation of 1000 mg Vitamin C for five days in these patients resulted in significant increases in these enzymes, compared to both pre- and post-thrombolytic therapy levels, as SOD and total thiol levels were at their highest following Vitamin C supplementation.
Likewise, levels of the oxygen radicals xanthine oxidase (XO) and malondialdehyde (MDA) were significantly elevated in ischemic patients in the post-reperfusion period compared to pre-thrombolytic therapy levels.
These oxygen radicals were significantly decreased following Vitamin C supplementation, compared to both pre- and post-thrombolytic therapy levels – XO and MDA levels were at their lowest in these patients following Vitamin C supplementation.
Heart and Muscle Contractility -
The Effects of Chemotherapy and Radiation on the Heart
In 2007, Yokoyama's team published the results of a Japanese study that investigated the effects of Vitamin C and dobutamine on myocardial contractility in patients with heart failure following anterior myocardial infarction. Dobutamine is a selective agonist that promotes increased cardiac output in patients with heart failure. Ten patients were selected for the Vitamin C group, with 9 controls.
Cardiac catheterization was performed to achieve direct measurement of several hemodynamic and contractile factors. This study found that Vitamin C significantly enhanced the response of left ventricular contractility and left ventricular stroke work, above the increases in these factors that occurred in response to ß-1 adrenergic stimulation.
Further, this enhancement of myocardial efficiency by Vitamin C did not result in increased myocardial oxygen consumption. These data suggest that Vitamin C is a safe and effective adjuvant therapy for patients with heart failure.
Take a Tour of Envita Medical Centers
In 2003, Martin and colleagues at Tufts Medical School published the findings of their investigation of plasma Vitamin C levels in patients following ischemic stroke. Fifteen ischemic stroke patients and 24 control subjects participated in this study. Plasma levels of Vitamin C and other oxidative stress and inflammatory markers were measured 2 to 5 days following ischemic events in the 15 subjects.
Despite having similar Vitamin C dietary intakes, ischemic stroke patients had significantly reduced plasma Vitamin C levels compared to controls, as measured by paired-ion, reverse-phase HPLC coupled with electrochemical detection. Interestingly, plasma Vitamin C levels had a strong inverse correlation with CRP levels in this cohort, suggesting that Vitamin C may play a critical role in the stroke-mediated inflammatory response.
Vitamin C for Stroke and Cancer Patients with Clotting Problems
In January 2008, Khaw and colleagues published peripheral findings from the ten-year European Prospective Investigation into Cancer (EPIC) study concerning Vitamin C and incidence of stroke. 20,649 men and women, ages 40 to 79 and without history of stroke at baseline, participated in this longitudinal study.
Participants submitted health questionnaires at various intervals over the ten-year time frame, per study protocol. Based on their responses to the study questionnaires, participants were stratified into four groups based on their reported daily Vitamin C intake. After evaluating participant questionnaires, the researchers found that those people in the quartile that reported the highest daily Vitamin C intake had a 42% lower relative risk of stroke than those people in the bottom quartile (lowest daily Vitamin C intake among study participants).
This decrease in relative stroke risk was found to be independent of age, sex, smoking habits, BMI, systolic blood pressure, cholesterol, physical activity, prevalent diabetes, myocardial infarction, social class, alcohol consumption, and any supplement use. Overall, the researchers reported that there was a 17% reduction in incident stroke for every 20 micromoles per liter increase in plasma Vitamin C concentration.
This peer-reviewed paper has demonstrated that Vitamin C is a warranted adjuvant therapy for patients with cancer. The in vitro cytotoxicity of Vitamin C has been noted in several different types of cancer cell lines, and ability of Vitamin C to enhance the effectiveness of chemotherapy has also been reported.
Clinical studies of Vitamin C supplementation in cancer patients have suggested that adjuvant use, especially by intravenous delivery, has therapeutic efficacy. The potent antioxidant activity of Vitamin C also results in direct enhancement in immune functioning. Supplementation of Vitamin C resulted in synergistic enhancement of triple antibiotic therapy in patients with H. pylori infection.
Recent publications have demonstrated that daily intake of Vitamin C is directly correlated with decreased risk of coronary heart disease, myocardial infarction, and stroke. Patients with myocardial infarction and/or ischemic stroke both present with decreased levels of Vitamin C shortly after symptom exacerbation. This decrease in Vitamin C levels has been shown to be statistically significant compared to control subjects.
Vitamin C supplementation in myocardial infarction patients resulted in increased levels of protective antioxidant enzymes and decreased levels of inflammatory and oxidative stress markers. Vitamin C worked synergistically with dobutamine in patients with heart failure secondary to anterior myocardial infarction, resulting in increased left ventricular contractility and stroke work. Importantly, the observed increase in left ventricular efficiency did not result in increased myocardial oxygen consumption.
Envita Medical Centers and Intravenous Vitamin C
Contact us to learn more about our speed drip intravenous Vitamin C technology, including our sustained released intravenous Vitamin C technology that we have found to be clinically superior to all others. In addition, we do not ever use corn-derived GMO Vitamin C with patients; rather, we utilize far cleaner sources that we believe makes a difference. Inquire today to learn more.
References
- Cameron E, Pauling L, Leibovitz B. Ascorbic acid and cancer: a review. Cancer Res. 1979 Mar;39(3):663-81. Review.
- Gonzalez MJ, Miranda-Massari JR, Mora EM, Guzman A, Riordan NH, Riordan HD, Casciari JJ, Jackson JA, Roman-Franco A. Orthomolecular oncology review: ascorbic acid and cancer 25 years later. Integr Cancer Ther. 2005 Mar;4(1):32-44. Review.
- Padayatty SJ, Sun H, Wang Y, Riordan HD, Hewitt SM, Katz A, Wesley RA, Levine M. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004 Apr 6;140(7):533-7.
- Casciari JJ, Riordan NH, Schmidt TL, Meng XL, Jackson JA, Riordan HD. Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours. Br J Cancer. 2001 Jun 1;84(11):1544-50.
- Chen Q, Espey MG, Krishna MC, Mitchell JB, Corpe CP, Buettner GR, Shacter E, Levine M. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13604-9. Epub 2005 Sep 12.
- Vissers MC, Gunningham SP, Morrison MJ, Dachs GU, Currie MJ. Modulation of hypoxia-inducible factor-1 alpha in cultured primary cells by intracellular ascorbate. Free Radic Biol Med. 2007 Mar 15;42(6):765-72.
- Knowles HJ, Raval RR, Harris AL, Ratcliffe PJ. Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. Cancer Res. 2003 Apr 15;63(8):1764-8.
- Karaczyn A, Ivanov S, Reynolds M, Zhitkovich A, Kasprzak KS, Salnikow K. Ascorbate depletion mediates up-regulation of hypoxia-associated proteins by cell density and nickel. J Cell Biochem. 2006 Apr 1;97(5):1025-35.
- Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. Proc Natl Acad Sci U S A. 1976 Oct;73(10):3685-9.
- Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer. Proc Natl Acad Sci U S A. 1978 Sep;75(9):4538-42.
- Padayatty SJ, Riordan HD, Hewitt SM, Katz A, Hoffer LJ, Levine M. Intravenously administered Vitamin C as cancer therapy: three cases. CMAJ. 2006 Mar 28;174(7):937-42.
- Yeom CH, Jung GC, Song KJ. Changes of Terminal Cancer Patients' Health-related Quality of Life after High Dose Vitamin C Administration. J Korean Med Sci. 2007 Feb;22(1):7-11.
- Lamson DW, Brignall MS. Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Altern Med Rev. 1999 Oct;4(5):304-29. Review.
- Drisko JA, Chapman J, Hunter VJ. The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer. J Am Coll Nutr. 2003 Apr;22(2):118-23.
- Wintergerst ES, Maggini S, Hornig DH. Immune-enhancing role of Vitamin C and zinc and effect on clinical conditions. Ann Nutr Metab. 2006;50(2):85-94.
- Hemila H. Vitamin C supplementation and respiratory infections: a systematic review. Mil Med. 2004 Nov;169(11):920-5. Review.
- Kodama M, Kodama T. Four problems with the clinical control of interstitial pneumonia, or chronic fatigue syndrome, using the megadose Vitamin C infusion system with dehydroepiandrosterone-cortisol annex. In Vivo. 2006 Mar-Apr;20(2):285-91.
- Kodama M, Kodama T. The clinical course of interstitial pneumonia alias chronic fatigue syndrome under the control of megadose Vitamin C infusion system with dehydroepiandrosterone-cortisol annex. Int J Mol Med. 2005 Jan;15(1):109-16.
- Chuang CH, Sheu BS, Kao AW, Cheng HC, Huang AH, Yang HB, Wu JJ. Adjuvant effect of Vitamin C on omeprazole-amoxicillin-clarithromycin triple therapy for Helicobacter pylori eradication. Hepatogastroenterology. 2007 Jan-Feb;54(73):320-4.
- Osganian SK, Stampfer MJ, Rimm E, Spiegelman D, Hu FB, Manson JE, Willett WC. Vitamin C and risk of coronary heart disease in women. J Am Coll Cardiol. 2003 Jul 16;42(2):246-52.
- Nam CM, Oh KW, Lee KH, Jee SH, Cho SY, Shim WH, Suh I. Vitamin C intake and risk of ischemic heart disease in a population with a high prevalence of smoking. J Am Coll Nutr. 2003 Oct;22(5):372-8.
- Bhakuni P, Chandra M, Misra MK. Effect of ascorbic acid supplementation on certain oxidative stress parameters in the post reperfusion patients of myocardial infarction. Mol Cell Biochem. 2006 Oct;290(1-2):153-8.
- Shinke T, Shite J, Takaoka H, Hata K, Inoue N, Yoshikawa R, Matsumoto H, Masai H, Watanabe S, Ozawa T, Otake H, Matsumoto D, Hirata K, Yokoyama M. Vitamin C restores the contractile response to dobutamine and improves myocardial efficiency in patients with heart failure after anterior myocardial infarction. Am Heart J. 2007 Oct;154(4):645.e1-8.
- Sánchez-Moreno C, Dashe JF, Scott T, Thaler D, Folstein MF, Martin A. Decreased levels of plasma Vitamin C and increased concentrations of inflammatory and oxidative stress markers after stroke. Stroke. 2004 Jan;35(1):163-8.
- Myint PK, Luben RN, Welch AA, Bingham SA, Wareham NJ, Khaw KT. Plasma Vitamin C concentrations predict risk of incident stroke over 10 y in 20 649 participants of the European Prospective Am J Clin Nutr. 2008 Jan;87(1):64-9.Investigation into Cancer Norfolk prospective population study.
Latest Cancer Articles
Metabolic and Gerson Therapies in Integrative Cancer Care
Metabolic and Gerson therapies focus on diet and detoxification to influence cancer metabolism. Envita integrates these principles within precision oncology, personalizing care with genomic testing and immune optimization to target cancer’s root drivers and improve patient outcomes.
Why Passive Cancer Monitoring May Increase Risk
Advanced diagnostics and targeted immunotherapies can reduce anxiety and improve follow-up care after cancer treatment
The watch-and-wait cancer approach may delay recurrence detection and limit treatment options. Envita Medical Centers uses precision oncology, liquid biopsies, and personalized immunotherapies to detect micro metastases early and reduce recurrence risks through active, targeted care.
Advocating for Medical Freedom in U.S. HealthcareEmpowering Patients and Physicians in the
Face of Chronic and Terminal Illness
Medical freedom empowers patients and doctors to choose personalized, evidence-based treatments beyond insurance restrictions. Envita Medical Centers champions healthcare freedom, offering integrative and precision options designed to improve outcomes and quality of life.
Value-Based Precision Oncology with Transparent Pricing
Envita’s value-based precision oncology combines advanced genomic testing, personalized immunotherapy, and transparent pricing to deliver patient-centered cancer care focused on results—not profits. This approach improves outcomes and lowers costs for cancer patients nationwide.
Employers Partner with COEs for Precision Cancer Care
Employers are partnering with Envita’s Center of Excellence to lower oncology costs and deliver precision cancer care. Using genomic testing and value-based treatments, Envita provides personalized therapies that improve outcomes and help employees recover with fewer side
On this page
- Intravenous Vitamin C: An Extraordinary Natural Chemotherapy and Immunotherapy Agent
- Vitamin C - Natural Cancer Treatment Serves Direct Cytotoxicity Killing on Cancer
- Vitamin C Works as an Anti-Angiogenic Agent
- More Encouraging Data for Vitamin C Utilized as an Chemotherapeutic Agent
- Vitamin C and Natural Treatment - NIH and it's Hisory with Pauling
- More Clinical Data Supporting Vitamin C as a Natural Cancer Treatment
- The Effects of Vitamin C on a Patient's Immune function
- Vitamin C - Helping 80% of Late Stage Cancer Patients Face Life-Threatening Infections
- Clinical Studies of Vitamin C in Relation to Cardiovascular Disease and Smoking
- Oxidative Stress
- Heart and Muscle Contractility - The Effects of Chemotherapy and Radiation on the Heart
- Vitamin C for Stroke and Cancer Patients with Clotting Problems
- Envita Medical Centers and Intravenous Vitamin C
- References
❖
❖
"Sugar literally shuts off the immune system and makes one more susceptible to all viruses, all infections.
When swallowing sugar... it goes inside the bone marrow and it suppresses—within 45 minutes—the body's ability to produce white blood cells that fight infections like
bacteria,
yeast,
viruses,
funguses, and parasites."
Dr. Bryan Ardis
“In the body is nature’s compound. If the tumor, infection, or inflammation suppresses it, we need to find a way to reactive it and clear the virus. It’s as simple as that.
Cancer is everything about the immune system.
When body becomes out of balance and killer cells become suppressed,
that’s when one gets cancer.” -
Dr. Patrick Soon-Shiong
When swallowing sugar... it goes inside the bone marrow and it suppresses—within 45 minutes—the body's ability to produce white blood cells that fight infections like
bacteria,
yeast,
viruses,
funguses, and parasites."
Dr. Bryan Ardis
“In the body is nature’s compound. If the tumor, infection, or inflammation suppresses it, we need to find a way to reactive it and clear the virus. It’s as simple as that.
Cancer is everything about the immune system.
When body becomes out of balance and killer cells become suppressed,
that’s when one gets cancer.” -
Dr. Patrick Soon-Shiong
❖
| vid-20260806-wa0000_copy.mp4 |
❖
Chris was diagnosed with stage 3 colon cancer
at 26 years old.
❖
Chris was diagnosed with stage 3 colon cancer
at 26 years old.
❖
That was 20 years ago. He was told he would need surgery and 9-12 months of chemotherapy, but he refused it and radically changed his diet and lifestyle and overdosed on nutrition with tons of juicing and giant salads and fresh fruit smoothies.
Instead of using fear to drive his decision on chemotherapy, he turned to facts and his faith. Instead of pumping chemo drugs into his body, he pumped in as many anti-cancer foods as he could and turned his body into a nutritional powerhouse. He built his body up instead of tearing it down. Fruits, vegetables, mushrooms, nuts, seeds, legumes, whole grains, herbs, and spices are the foundational ingredients of Chris's anticancer diet
4 Factors how to get cancer:
Diet, Lifestyle Choices, Exercise, and Stress.
They either promote health or disease.
Do not be afraid.
Cancer is a natural and normal process in the body.
Everyone has cancer cells.
The body is designed to recognize them and eliminate when a cell mutates and becomes cancer. Cancer is not the real problem. The real problem is one is sick and has a systemic metabolic disease that is resulting in a tumor or tumors that are growing. The tumor is the symptom. Cancer is a result of a body that is nutrient deficient and overloaded with toxins and the result of a suppressed and overloaded immune system.
There are 3 kinds of cancer patients.
1. 5-15% of cancer patients are ready to die. They don't want to get well and that is okay.
2. 60% of cancer patients are the conventionally minded patient and just want to do what the doctor says. These people have a strong will to live and will do whatever it takes including whatever brutal therapy/poison.
3. 10-15% of cancer patients are willing to do whatever it takes to get well. They are willing to change their entire life. They are willing to do stop doing the things that are destroying their life. They are willing to stop doing the things that are making them sick. They are willing to start doing a lot of new and weird things including enemas.
If you have cancer, do you want to get well? That is the most important question one can ask themselves.
There is something more important than fear. Faith. Don't let fear paralyze or cripple us.
Fear and faith cannot coexist.
Either we are operating in a position of fear or a position of faith. People make fear based decisions.
Removes the fear, confusion, and overwhelming that cancer patients face. Replaces it with Hope, Clarity, Confidence, Action Plan
Zero family members will ask for advice when they get cancer.
Doesn't matter how many experts or other cancer survivors that have been interviewed that have reversed terminal pancreatic cancer.
Do I want to get well? Do I want to live? Am I willing to change my entire life? Am I willing to forgive the people that have hurt me? Forgiveness is forever. Forgiveness is like a healthy diet. A healthy diet doesn't work if we only eat a healthy lunch.
A healthy diet only helps us if we stick to it for life.
If we go back to the Standard American Diet, we will become at risk to develop a typical standard American disease like cancer, heart disease or diabetes.
Forgiveness is the same thing where many fail to understand.
Our mental attitude and the decisions we make are so important.
We need to love what we are doing by juicing or by chemotherapy. That is supposed to be medicine, but they are despising it and hating it with every ounce of their being. How well does this work out when we hate something that is put into us? We are infusing that hatred and emotion with a toxic chemical in our body.
We want to love our medicine, love what we are doing by being thankful and grateful for our life by eating food from the earth that are rich in an abundant of vitamins, minerals, nutrients, enzymes, and phytonutrients that will nourish.
When we take control of our life, we empower ourselves. When we give all our faith, hope, and trust to a doctor, we empower them and we lose all of our power and become helpless and dependent on them to save us.
The truth is, they cannot do it. Our faith needs to be in God first and ourselves second and a doctor to work with us third.
Don't do anything that doesn't make sense to us.
We need accountability and support and we need people to work with you. This is the best time to have cancer.
There never been more encouragement, support, and resources that exists right now.
Obstacles come into our life for a reason. They come into our life to be overcome. When one of these trials or adversity come into our life, it is to make us stronger, to change or divert us to set us up for blessing in life.
Blessings come disguised as problems.
We live in a culture who nobody wants to blame themselves. In the cancer community, they want to pat us on the head and say it is not your fault or is nothing we did. It's just genetic. We don't know why, but it's not your fault. Just have a frosty and double cheeseburger. Whatever you do, don't drink carrot juice. It is too much sugar. Take responsibility in ourselves.
What Every Cancer Patient Needs To Know - Health Tips For Cancer Patients
First thing to understand about cancer:
1. Do not be afraid. Cancer is a natural and normal process in the body. Everyone has cancer cells. The body is designed to recognize them and eliminate when a cell mutates and becomes cancer.
2. Cancer is not the real problem. The real problem is you are sick and have a systemic metabolic disease that is resulting in a tumor or tumors that are growing. The tumor is the symptom.
3. Cancer is a result of a body that is nutrient deficient and overloaded with toxins and the result of a suppressed and overloaded immune system.
4. Cancer has tripled in the last 100 years. If we compare our lifestyle, processed food that we were never designed to eat. We need to get back to food that is coming straight out of the earth in their natural form of fruits and vegetables. The earth was created for us and everything we need comes from the earth.
5. The problem is we are over fed, but malnourished. We are getting plenty of fat, protein and carbs, but not receiving valuable micronutrients: vitamins, minerals, enzymes, antioxidants, and phytonutrient compounds in fruits and vegetables.
6. If we drink, smoke, and take pharmaceutical drugs are all suppressing the immune system and cancer promoting.
7. Pharmaceutical drugs do not heal. They only mask and alleviate symptoms. The only way to true healing is through nutrition to give our body all the building blocks to repair and generate.
8. Obesity is the second leading cause of cancer. If we are overweight, it is pro cancerous. Our body is in chronic state and overloaded and struggling.
9. Lack of exercise. When we exercise, we are sending signals of life to our body to grow and get stronger.
10. Stress destroys our immune system. It suppresses our immune system including relationship stress, work stress, too much exercise like marathon running. All stresses are immunosuppressant. If there are people in our life we have not forgiven, harboring negative emotions like unforgivness and bitterness and jealousy, judgmental, critical, and always negative, then we are in a chronic state of inflammation and stress. Stress hormones are elevated, cortisol and adrenalin elevated and that is pro cancerous conditions.
11. 4 Factors: Diet, Lifestyle Choices, Exercise, and Stress are four factors how to get cancer. They either promote health or disease.
12. Don't let anyone rush us into surgery chemo or radiation. The majority of cancers are not life-threatening and they're not emergency situations. The majority of people diagnosed with cancer feel fine. Most doctors will admit you have some time.
13. Tell your doctor I would really like to take some time to change my life. Can I have 30, 60, or 60 days? During this time, radically change your diet and lifestyle and see what happens. That is the absolute best approach. The results from many include losing weight, reversing chronic heart disease conditions, lowering cholesterol, lower blood pressure, and shrinking tumors to almost nothing by just changing the diet and feeding the body and giving everything it needs to repair, regenerate, and detoxify.
14. The medical view of cancer is that its linear. Once they find a cancerous tumor, it can only go one direction by growing and spreading all over the body. The latest clinical research has proven that to be false because we know that the body can heal cancer. They call that spontaneous regression (healing). The body created it and the body can heal it. We just have to give it the proper nutrients and care.
15. Learn more and start reading and researching and reading of other survivors that healed themselves. We can learn from the experience from others. www.chrisbeatcancer.com
16. Take your time and don't let anyone rush us. Listen to our instincts. Do not do something that you don't feel good about. If you don't feel good about surgery. If you don't feel good about chemotherapy or radiation, do not consent. This is your life. You are in control. You make decisions and it is your life.
17. Pray. Ask God to reveal himself to you if you don't know him and lead you into the path of healing to show you the way. When we step out in faith and to the unknown, amazing things will happen in our life. Miracles will happen. God will reveal himself to you. He will show you the way and light the path.
SAY NO TO IMMUNE SUPPRESSING AND CANCER PROMOTING FOOD AND DRUGS.
https://sq1.chrisbeatcancer.com/go?utm_medium=email...
Instead of using fear to drive his decision on chemotherapy, he turned to facts and his faith. Instead of pumping chemo drugs into his body, he pumped in as many anti-cancer foods as he could and turned his body into a nutritional powerhouse. He built his body up instead of tearing it down. Fruits, vegetables, mushrooms, nuts, seeds, legumes, whole grains, herbs, and spices are the foundational ingredients of Chris's anticancer diet
4 Factors how to get cancer:
Diet, Lifestyle Choices, Exercise, and Stress.
They either promote health or disease.
Do not be afraid.
Cancer is a natural and normal process in the body.
Everyone has cancer cells.
The body is designed to recognize them and eliminate when a cell mutates and becomes cancer. Cancer is not the real problem. The real problem is one is sick and has a systemic metabolic disease that is resulting in a tumor or tumors that are growing. The tumor is the symptom. Cancer is a result of a body that is nutrient deficient and overloaded with toxins and the result of a suppressed and overloaded immune system.
There are 3 kinds of cancer patients.
1. 5-15% of cancer patients are ready to die. They don't want to get well and that is okay.
2. 60% of cancer patients are the conventionally minded patient and just want to do what the doctor says. These people have a strong will to live and will do whatever it takes including whatever brutal therapy/poison.
3. 10-15% of cancer patients are willing to do whatever it takes to get well. They are willing to change their entire life. They are willing to do stop doing the things that are destroying their life. They are willing to stop doing the things that are making them sick. They are willing to start doing a lot of new and weird things including enemas.
If you have cancer, do you want to get well? That is the most important question one can ask themselves.
There is something more important than fear. Faith. Don't let fear paralyze or cripple us.
Fear and faith cannot coexist.
Either we are operating in a position of fear or a position of faith. People make fear based decisions.
Removes the fear, confusion, and overwhelming that cancer patients face. Replaces it with Hope, Clarity, Confidence, Action Plan
Zero family members will ask for advice when they get cancer.
Doesn't matter how many experts or other cancer survivors that have been interviewed that have reversed terminal pancreatic cancer.
Do I want to get well? Do I want to live? Am I willing to change my entire life? Am I willing to forgive the people that have hurt me? Forgiveness is forever. Forgiveness is like a healthy diet. A healthy diet doesn't work if we only eat a healthy lunch.
A healthy diet only helps us if we stick to it for life.
If we go back to the Standard American Diet, we will become at risk to develop a typical standard American disease like cancer, heart disease or diabetes.
Forgiveness is the same thing where many fail to understand.
Our mental attitude and the decisions we make are so important.
We need to love what we are doing by juicing or by chemotherapy. That is supposed to be medicine, but they are despising it and hating it with every ounce of their being. How well does this work out when we hate something that is put into us? We are infusing that hatred and emotion with a toxic chemical in our body.
We want to love our medicine, love what we are doing by being thankful and grateful for our life by eating food from the earth that are rich in an abundant of vitamins, minerals, nutrients, enzymes, and phytonutrients that will nourish.
When we take control of our life, we empower ourselves. When we give all our faith, hope, and trust to a doctor, we empower them and we lose all of our power and become helpless and dependent on them to save us.
The truth is, they cannot do it. Our faith needs to be in God first and ourselves second and a doctor to work with us third.
Don't do anything that doesn't make sense to us.
We need accountability and support and we need people to work with you. This is the best time to have cancer.
There never been more encouragement, support, and resources that exists right now.
Obstacles come into our life for a reason. They come into our life to be overcome. When one of these trials or adversity come into our life, it is to make us stronger, to change or divert us to set us up for blessing in life.
Blessings come disguised as problems.
We live in a culture who nobody wants to blame themselves. In the cancer community, they want to pat us on the head and say it is not your fault or is nothing we did. It's just genetic. We don't know why, but it's not your fault. Just have a frosty and double cheeseburger. Whatever you do, don't drink carrot juice. It is too much sugar. Take responsibility in ourselves.
What Every Cancer Patient Needs To Know - Health Tips For Cancer Patients
First thing to understand about cancer:
1. Do not be afraid. Cancer is a natural and normal process in the body. Everyone has cancer cells. The body is designed to recognize them and eliminate when a cell mutates and becomes cancer.
2. Cancer is not the real problem. The real problem is you are sick and have a systemic metabolic disease that is resulting in a tumor or tumors that are growing. The tumor is the symptom.
3. Cancer is a result of a body that is nutrient deficient and overloaded with toxins and the result of a suppressed and overloaded immune system.
4. Cancer has tripled in the last 100 years. If we compare our lifestyle, processed food that we were never designed to eat. We need to get back to food that is coming straight out of the earth in their natural form of fruits and vegetables. The earth was created for us and everything we need comes from the earth.
5. The problem is we are over fed, but malnourished. We are getting plenty of fat, protein and carbs, but not receiving valuable micronutrients: vitamins, minerals, enzymes, antioxidants, and phytonutrient compounds in fruits and vegetables.
6. If we drink, smoke, and take pharmaceutical drugs are all suppressing the immune system and cancer promoting.
7. Pharmaceutical drugs do not heal. They only mask and alleviate symptoms. The only way to true healing is through nutrition to give our body all the building blocks to repair and generate.
8. Obesity is the second leading cause of cancer. If we are overweight, it is pro cancerous. Our body is in chronic state and overloaded and struggling.
9. Lack of exercise. When we exercise, we are sending signals of life to our body to grow and get stronger.
10. Stress destroys our immune system. It suppresses our immune system including relationship stress, work stress, too much exercise like marathon running. All stresses are immunosuppressant. If there are people in our life we have not forgiven, harboring negative emotions like unforgivness and bitterness and jealousy, judgmental, critical, and always negative, then we are in a chronic state of inflammation and stress. Stress hormones are elevated, cortisol and adrenalin elevated and that is pro cancerous conditions.
11. 4 Factors: Diet, Lifestyle Choices, Exercise, and Stress are four factors how to get cancer. They either promote health or disease.
12. Don't let anyone rush us into surgery chemo or radiation. The majority of cancers are not life-threatening and they're not emergency situations. The majority of people diagnosed with cancer feel fine. Most doctors will admit you have some time.
13. Tell your doctor I would really like to take some time to change my life. Can I have 30, 60, or 60 days? During this time, radically change your diet and lifestyle and see what happens. That is the absolute best approach. The results from many include losing weight, reversing chronic heart disease conditions, lowering cholesterol, lower blood pressure, and shrinking tumors to almost nothing by just changing the diet and feeding the body and giving everything it needs to repair, regenerate, and detoxify.
14. The medical view of cancer is that its linear. Once they find a cancerous tumor, it can only go one direction by growing and spreading all over the body. The latest clinical research has proven that to be false because we know that the body can heal cancer. They call that spontaneous regression (healing). The body created it and the body can heal it. We just have to give it the proper nutrients and care.
15. Learn more and start reading and researching and reading of other survivors that healed themselves. We can learn from the experience from others. www.chrisbeatcancer.com
16. Take your time and don't let anyone rush us. Listen to our instincts. Do not do something that you don't feel good about. If you don't feel good about surgery. If you don't feel good about chemotherapy or radiation, do not consent. This is your life. You are in control. You make decisions and it is your life.
17. Pray. Ask God to reveal himself to you if you don't know him and lead you into the path of healing to show you the way. When we step out in faith and to the unknown, amazing things will happen in our life. Miracles will happen. God will reveal himself to you. He will show you the way and light the path.
SAY NO TO IMMUNE SUPPRESSING AND CANCER PROMOTING FOOD AND DRUGS.
https://sq1.chrisbeatcancer.com/go?utm_medium=email...
❖